Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Peter Pickkers and Roger Brüggemann.
Peter Pickkers
Connection Strength
0.715
Roger Brüggemann
  1. Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals. Int J Antimicrob Agents. 2021 Mar; 57(3):106293.
    View in: PubMed
    Score: 0.232
  2. Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole. Br J Clin Pharmacol. 2018 09; 84(9):1980-1988.
    View in: PubMed
    Score: 0.193
  3. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients. Clin Pharmacokinet. 2017 10; 56(10):1197-1206.
    View in: PubMed
    Score: 0.184
  4. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. J Infect Dis. 2021 04 23; 223(8):1322-1333.
    View in: PubMed
    Score: 0.059
  5. Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial. JAMA. 2018 02 20; 319(7):680-690.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.